Literature DB >> 12918126

Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.

Jia-Hua Zhou1, Hong-Mei Zhang, Quan Chen, Dong-Dong Han, Fei Pei, Li-Shan Zhang, De-Tong Yang.   

Abstract

AIM: To directly investigate the relationship between telomerase activity and its subunit expression and the inhibitory effect of antisense hTR on pancreatic carcinogenesis.
METHODS: We examined the telomerase activity and its subunit expression by cell culture, polymerase chain reaction (PCR), PCR-silver staining, PCR-ELISA, DNA sequencing, MTT and flow cytometry methods.
RESULTS: PCR-silver staining and PCR-ELISA methods had the same specificity and sensitivity as the TRAP method. Telomerase activity was detected in the extract of the 10(th),20(th) and 30(th) passages of P3 cells,while it was absent in fibroblasts. Furthermore, after the 30th generation, the proliferation period of fibroblast cells was significantly prolonged. Telomerase activity and hTERTmRNA were detected in two pancreatic carcinoma cell lines, but were found to be negative in human fibroblast cells. Telomerase activity and hTERTmRNA were tested in pancreatic carcinoma specimens of 24 cases. The telomerase activity was positive in 21 of the 24 cases (87.5 %), and the hTERTmRNA in 20 cases (83.3 %). In adjacent normal tissues positive rates were both 12.5 %. There was a significant difference between the two groups. This indicated a significant correlation between the expression level of telomerase activity and histologic differentiation, metastasis and advanced clinical stage of pancreatic carcinoma. Our findings showed that the expressions of hTR and TP1mRNA were not correlated with the activity of telomerase but the expression of hTERTmRNA was. After treatment with PS-ODNs, telomerase activity in P(3) cells weakened and the inhibiting effect became stronger with an increase in PS-ODNs concentration. There was a significant difference between different PS-ODN groups (P<0.05). Inhibition of telomerase activity occurred most significant with PS-ODN1. The results of the FCM test of pancreatic cancer P(3) cells showed an increase in the apoptotic rate with increasing PS-ODN1 and PS-ODN2 concentrations.
CONCLUSION: The expression of telomerase activity has a significant relationship to carcinogenesis. A strong correlation exists between telomerase activity and hTERTmRNA expression. The up-regulation of hTERTmRNA expression may play a critical role in human carcinogenesis. The expression of telomerase activity and its subunit level in pancreatic carcinoma significantly correlate with the clinical stage of pancreatic carcinoma and hence, may be helpful in its diagnosis and prognosis. The anti-hTR complementary to the template region of hTR is sufficient to inhibit P3 cell telomerase activity and cell proliferation in vitro, and can lead to a profound induction of programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918126      PMCID: PMC4611549          DOI: 10.3748/wjg.v9.i8.1808

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes.

Authors:  C Härle-Bachor; P Boukamp
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer.

Authors:  T Suzuki; Y Suzuki; T Fujioka
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

3.  Telomerase activity in benign and malignant epithelial ovarian tumors.

Authors:  M Wan; W Z Li; B D Duggan; J C Felix; Y Zhao; L Dubeau
Journal:  J Natl Cancer Inst       Date:  1997-03-19       Impact factor: 13.506

4.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

5.  Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence.

Authors:  K Ohta; T Kanamaru; Y Morita; Y Hayashi; H Ito; M Yamamoto
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

6.  Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.

Authors:  Zhong-Ying Shen; Li-Yan Xu; En-Min Li; Wei-Jia Cai; Min-Hua Chen; Jian Shen; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

7.  Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.

Authors:  M Takakura; S Kyo; T Kanaya; M Tanaka; M Inoue
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

8.  [Expression and clinical significance of telomerase catalytic subunit gene in lung cancer and its correlations with genes related to drug resistance and apoptosis].

Authors:  J Wang; X Liu; J Fang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1999-09

9.  Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.

Authors:  K Seki; T Suda; Y Aoyagi; S Sugawara; M Natsui; H Motoyama; Y Shirai; T Sekine; H Kawai; Y Mita; N Waguri; T Kuroiwa; M Igarashi; H Asakura
Journal:  Clin Cancer Res       Date:  2001-07       Impact factor: 12.531

Review 10.  Telomerase as a new target for pancreatic cancer treatment.

Authors:  Norihiro Sato; Kazuhiro Mizumoto; Eishi Nagai; Masao Tanaka
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002
View more
  5 in total

1.  Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth in vitro.

Authors:  Yun-Feng Wang; Ke-Jian Guo; Bei-Ting Huang; Yong Liu; Xiao-Yun Tang; Jian-Jun Zhang; Qiang Xia
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

2.  Value of endoscopic methylene blue and Lugol's iodine double staining and detection of GST-Pi and telomerase in the early diagnosis of esophageal carcinoma.

Authors:  Xuan Zhu; Shuang-Hong Zhang; Kun-He Zhang; Bi-Ming Li; Jiang Chen
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

3.  Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activity.

Authors:  Ruiguan Wang; Jiangbo Li; Changjian Zhang; Xin Guan; Boyu Qin; Rui Jin; Lingmei Qin; Shanrong Xu; Xiaona Zhang; Rong Liu; Qinong Ye; Long Cheng
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

4.  The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters.

Authors:  Saied Hosseini-Asl; Morteza Atri; Mohammad H Modarressi; Mohamed Salhab; Kefah Mokbel; Parvin Mehdipour
Journal:  Int Semin Surg Oncol       Date:  2006-08-22

Review 5.  The dark side of immunotherapy: pancreatic cancer.

Authors:  Gianluca Mucciolo; Cecilia Roux; Alessandro Scagliotti; Silvia Brugiapaglia; Francesco Novelli; Paola Cappello
Journal:  Cancer Drug Resist       Date:  2020-05-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.